Ironwood Pharmaceuticals Q2 Revenue USD 113.041 Million Vs. IBES Estimate USD 114.8 Million
IRWD•Second-quarter financial results
Aug. 6 (Reuters) - Ironwood Pharmaceuticals Q2 adjusted EBITDA was USD 83.042 million.
- Q2 net income was USD 51.291 million
- Q2 EPS was USD 0.31
- Q2 basic EPS was USD 0.31
- Q2 adjusted net income was USD 51.495 million
